Terms: = Ovarian cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Staging
51 results:
1. Validating the 2023 FIGO staging system: A nomogram for endometrioid endometrial cancer and adenocarcinoma.
Feng Y; Miao F; Li Y; Li M; Cao Y
Cancer Med; 2024 May; 13(10):e7216. PubMed ID: 38752451
[TBL] [Abstract] [Full Text] [Related]
2. Diagnosing and staging epithelial ovarian cancer by serum glycoproteomic profiling.
Dhar C; Ramachandran P; Xu G; Pickering C; Čaval T; Wong M; Rice R; Zhou B; Srinivasan A; Aiyetan P; Chu CW; Moser K; Herzog TJ; Olawaiye AB; Jacob F; Serie D; Lindpaintner K; Schwarz F
Br J Cancer; 2024 Jun; 130(10):1716-1724. PubMed ID: 38658783
[TBL] [Abstract] [Full Text] [Related]
3. Identification of prognostic factors and construction of nomogram to predict cancer-specific survival for patients with ovarian granulosa cell tumors.
Zhang Y; Zhang Z; Ding X; Zhang K; Dai Y; Cheng W; Luo C
Cancer Rep (Hoboken); 2024 Mar; 7(3):e2046. PubMed ID: 38507268
[TBL] [Abstract] [Full Text] [Related]
4. Assessment of endometrial carcinoma on biopsy as a predictor of final surgical pathology: Are we doing it right? A completed audit cycle and recommendations.
Jassar A; Hemali N; Bhatnagar A
Indian J Pathol Microbiol; 2024; 67(1):68-73. PubMed ID: 38358191
[TBL] [Abstract] [Full Text] [Related]
5. The OCDA-Net: a 3D convolutional neural network-based system for classification and staging of ovarian cancer patients using [
Sadeghi MH; Sina S; Alavi M; Giammarile F
Ann Nucl Med; 2023 Dec; 37(12):645-654. PubMed ID: 37768493
[TBL] [Abstract] [Full Text] [Related]
6. ROMA Index Is an Effective Predictor for Advanced Endometrial cancer before Surgery.
Wang J; Xu P; Zou G; Yin M; Mao X; Zhang X
Dis Markers; 2022; 2022():7409368. PubMed ID: 36590753
[TBL] [Abstract] [Full Text] [Related]
7. Management of patients with early-stage ovarian clear cell carcinoma: risk stratification and fertility conservation.
Manning-Geist B; Gordhandas S; Hodgson A; Zhou QC; Iasonos A; Chi DS; Ellenson L; Aghajanian CA; Abu-Rustum NR; Leitao M; Long K; Rubinstein MM; Sonoda Y; Alektiar K; Weigelt B; Zivanovic O; Grisham RN
Int J Gynecol Cancer; 2022 Dec; 32(12):1576-1582. PubMed ID: 36368707
[TBL] [Abstract] [Full Text] [Related]
8. Data set for the Reporting of ovarian, Fallopian Tube and Primary Peritoneal Carcinoma: Recommendations From the International Collaboration on cancer Reporting (ICCR).
Gilks CB; Selinger CI; Davidson B; Köbel M; Ledermann JA; Lim D; Malpica A; Mikami Y; Singh N; Srinivasan R; Vang R; Lax SF; McCluggage WG
Int J Gynecol Pathol; 2022 Nov; 41(Suppl 1):S119-S142. PubMed ID: 36305537
[TBL] [Abstract] [Full Text] [Related]
9. Prediction Model of Residual Neural Network for Pathological Confirmed Lymph Node Metastasis of ovarian cancer.
Yao H; Zhang X
Biomed Res Int; 2022; 2022():9646846. PubMed ID: 36267845
[TBL] [Abstract] [Full Text] [Related]
10. Effect of Hospital Case-Volume on Mortality after ovarian cancer Surgery: A Population-Based Retrospective Cohort Study.
Kim BR; Kim H; Joo SG; Jang EJ; Jo J; Lee H; Ryu HG
Gynecol Obstet Invest; 2022; 87(6):364-372. PubMed ID: 36044873
[TBL] [Abstract] [Full Text] [Related]
11. Development of a radiomic-clinical nomogram for prediction of survival in patients with serous ovarian cancer.
Hong Y; Liu Z; Lin D; Peng J; Yuan Q; Zeng Y; Wang X; Luo C
Clin Radiol; 2022 May; 77(5):352-359. PubMed ID: 35264303
[TBL] [Abstract] [Full Text] [Related]
12. Nomogram for predicting postoperative cancer-specific early death in patients with epithelial ovarian cancer based on the SEER database: a large cohort study.
Zhang T; Zhu L
Arch Gynecol Obstet; 2022 Jun; 305(6):1535-1549. PubMed ID: 34841445
[TBL] [Abstract] [Full Text] [Related]
13. Nomograms for Predicting Overall Survival and cancer-Specific Survival of Young Patients with Epithelial ovarian cancer: Analysis Based on SEER Program.
Gao J; Wang S; Li F; Xu H; Li X; Yan L; Zhu L
Adv Ther; 2022 Jan; 39(1):257-285. PubMed ID: 34716558
[TBL] [Abstract] [Full Text] [Related]
14. Surgical Technique for Sentinel Lymph Node Sampling in Presumed Early-stage ovarian cancer.
Matanes E; Gupta V; Kogan L; Racicot J; Salvador S; Gotlieb WH; Lau S
J Minim Invasive Gynecol; 2021 Aug; 28(8):1446. PubMed ID: 33387689
[TBL] [Abstract] [Full Text] [Related]
15. What are the implications of using individual and combined sources of routinely collected data to identify and characterise incident site-specific cancers? a concordance and validation study using linked English electronic health records data.
Strongman H; Williams R; Bhaskaran K
BMJ Open; 2020 Aug; 10(8):e037719. PubMed ID: 32819994
[TBL] [Abstract] [Full Text] [Related]
16. Acceptability of quality indicators for the management of endometrial, cervical and ovarian cancer: results of an online survey.
Luyckx A; Wyckmans L; Bonte AS; Trinh XB; van Dam PA
BMC Womens Health; 2020 Jul; 20(1):151. PubMed ID: 32703282
[TBL] [Abstract] [Full Text] [Related]
17. Pseudovascular Invasion: Minimally Invasive Surgery for Endometrial cancer.
Seifi F; Parkash V; Clark M; Menderes G; Tierney C; Silasi DA; Azodi M
JSLS; 2019; 23(2):. PubMed ID: 31285650
[TBL] [Abstract] [Full Text] [Related]
18. Key Immunological Functions Involved in the Progression of Epithelial ovarian Serous Carcinoma Discovered by the Gene Ontology-Based Immunofunctionome Analysis.
Chang CC; Su KM; Lu KH; Lin CK; Wang PH; Li HY; Wang ML; Lin CK; Yu MH; Chang CM
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30356023
[TBL] [Abstract] [Full Text] [Related]
19. Quality indicators for the management of endometrial, cervical and ovarian cancer.
Bonte AS; Luyckx A; Wyckmans L; Trinh XB; van Dam PA
Eur J Surg Oncol; 2019 Apr; 45(4):528-537. PubMed ID: 30337202
[TBL] [Abstract] [Full Text] [Related]
20. Distinct molecular pathways in ovarian endometrioid adenocarcinoma with concurrent endometriosis.
Zhang C; Wang X; Anaya Y; Parodi L; Cheng L; Anderson ML; Hawkins SM
Int J Cancer; 2018 Nov; 143(10):2505-2515. PubMed ID: 30152524
[TBL] [Abstract] [Full Text] [Related]
[Next]
